Rosa Capozzo1, Stefano Zoccolella2, Marco Musio1, Roberta Barone1, Miriam Accogli1, Giancarlo Logroscino1,3. 1. Center for Neurodegenerative Disease and The Aging Brain at the Hospital "C. Panico" Tricase (Lecce), University of Bari, Tricase, Italy. 2. Neurology Unit, ASL Bari, San Paolo Hospital, Bari, Italy, and. 3. Department of Basic Medicine, Neuroscience and Sense Organs, University of Bari, Italy.
Abstract
BACKGROUND: Teleneurology is an effective tool for the rapid evaluation of patients in remote locations with a well-established use in stroke and epilepsy. To date its adoption for Amyotrophic Lateral Sclerosis (ALS) care is still in a preliminary stage. We evaluated the feasibility of multidisciplinary assessment of patients with ALS, using telememedicine during the emergency determined by the COVID-19 pandemic. Methods: All patients included in this survey had received a diagnosis of ALS according to international criteria after a complete clinical and paraclinical assessment during 2019. A structured questionnaire was used by the neurologist with the patient or the caregiver. A video interaction was offered but refused by all patients because they did not feel comfortable or did not have smartphone. Results: Out of 31 clinical interviews 8 were completed directly with the patients and 23 with patients' caregivers. In a successive survey, most of patients were satisfied with the neurological interview (85%), the possibility to interact directly with the clinician being at home (85%) and reduction of economic and time costs because they avoided unnecessary travel to the clinic. Most of subjects expressed their willingness to continue to be included in remote evaluation programs (90%). Notably, none of the patients presented index symptoms of Covid-19 infection. Conclusion: Our study indicates that telemedicine is a valid tool to triage patients with ALS to increase practice outreach and efficiency. Delivery of care via telemedicine was effective and successful in people with ALS in the dramatic and sudden crisis determined by Covid-19 outbreak.
BACKGROUND: Teleneurology is an effective tool for the rapid evaluation of patients in remote locations with a well-established use in stroke and epilepsy. To date its adoption for Amyotrophic Lateral Sclerosis (ALS) care is still in a preliminary stage. We evaluated the feasibility of multidisciplinary assessment of patients with ALS, using telememedicine during the emergency determined by the COVID-19 pandemic. Methods: All patients included in this survey had received a diagnosis of ALS according to international criteria after a complete clinical and paraclinical assessment during 2019. A structured questionnaire was used by the neurologist with the patient or the caregiver. A video interaction was offered but refused by all patients because they did not feel comfortable or did not have smartphone. Results: Out of 31 clinical interviews 8 were completed directly with the patients and 23 with patients' caregivers. In a successive survey, most of patients were satisfied with the neurological interview (85%), the possibility to interact directly with the clinician being at home (85%) and reduction of economic and time costs because they avoided unnecessary travel to the clinic. Most of subjects expressed their willingness to continue to be included in remote evaluation programs (90%). Notably, none of the patients presented index symptoms of Covid-19infection. Conclusion: Our study indicates that telemedicine is a valid tool to triage patients with ALS to increase practice outreach and efficiency. Delivery of care via telemedicine was effective and successful in people with ALS in the dramatic and sudden crisis determined by Covid-19 outbreak.
Authors: Tiago S Jesus; Sutanuka Bhattacharjya; Christina Papadimitriou; Yelena Bogdanova; Jacob Bentley; Juan Carlos Arango-Lasprilla; Sureshkumar Kamalakannan Journal: Int J Environ Res Public Health Date: 2021-06-08 Impact factor: 3.390
Authors: Sonu Bhaskar; Sian Bradley; Vijay Kumar Chattu; Anil Adisesh; Alma Nurtazina; Saltanat Kyrykbayeva; Sateesh Sakhamuri; Sebastian Moguilner; Shawna Pandya; Starr Schroeder; Maciej Banach; Daniel Ray Journal: Front Public Health Date: 2020-09-07
Authors: Kathy Y Liu; Robert Howard; Sube Banerjee; Adelina Comas-Herrera; Joanne Goddard; Martin Knapp; Gill Livingston; Jill Manthorpe; John T O'Brien; Ross W Paterson; Louise Robinson; Martin Rossor; James B Rowe; David J Sharp; Andrew Sommerlad; Aida Suárez-González; Alistair Burns Journal: Int J Geriatr Psychiatry Date: 2021-05-27 Impact factor: 3.850